These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 19558533)
1. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Weigert J; Neumeier M; Wanninger J; Filarsky M; Bauer S; Wiest R; Farkas S; Scherer MN; Schäffler A; Aslanidis C; Schölmerich J; Buechler C Clin Endocrinol (Oxf); 2010 Mar; 72(3):342-8. PubMed ID: 19558533 [TBL] [Abstract][Full Text] [Related]
2. Reduced serum chemerin in patients with more severe liver cirrhosis. Eisinger K; Krautbauer S; Wiest R; Weiss TS; Buechler C Exp Mol Pathol; 2015 Apr; 98(2):208-13. PubMed ID: 25595667 [TBL] [Abstract][Full Text] [Related]
3. The adipokine Chemerin and Fetuin-A Serum Levels in Type 2 Diabetes Mellitus: Relation to Obesity and Inflammatory Markers. El-Deeb TS; Bakkar SM; Eltoony L; Zakhary MM; Kamel AA; Nafee AM; Hetta HF Egypt J Immunol; 2018 Jan; 25(1):191-202. PubMed ID: 30243011 [TBL] [Abstract][Full Text] [Related]
4. Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes. Weigert J; Neumeier M; Wanninger J; Bauer S; Farkas S; Scherer MN; Schnitzbauer A; Schäffler A; Aslanidis C; Schölmerich J; Buechler C J Clin Endocrinol Metab; 2010 Mar; 95(3):1404-11. PubMed ID: 20080851 [TBL] [Abstract][Full Text] [Related]
5. Relationship of serum novel adipokine chemerin levels with body composition, insulin resistance, dyslipidemia and diabesity in Saudi women. Habib SS; Eshki A; AlTassan B; Fatani D; Helmi H; AlSaif S Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1296-1302. PubMed ID: 28387898 [TBL] [Abstract][Full Text] [Related]
6. Serum Chemerin Levels Are Associated with Abdominal Visceral Fat in Type 2 Diabetes. Han J; Kim SH; Suh YJ; Lim HA; Shin H; Cho SG; Kim CW; Lee SY; Lee DH; Hong S; Kim YS; Nam MS J Korean Med Sci; 2016 Jun; 31(6):924-31. PubMed ID: 27247502 [TBL] [Abstract][Full Text] [Related]
7. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Chakaroun R; Raschpichler M; Klöting N; Oberbach A; Flehmig G; Kern M; Schön MR; Shang E; Lohmann T; Dreßler M; Fasshauer M; Stumvoll M; Blüher M Metabolism; 2012 May; 61(5):706-14. PubMed ID: 22136911 [TBL] [Abstract][Full Text] [Related]
8. The increase of serum chemerin concentration is mainly associated with the increase of body mass index in obese, non-diabetic subjects. Sledzinski T; Korczynska J; Hallmann A; Kaska L; Proczko-Markuszewska M; Stefaniak T; Sledzinski M; Swierczynski J J Endocrinol Invest; 2013 Jun; 36(6):428-34. PubMed ID: 23211604 [TBL] [Abstract][Full Text] [Related]
9. Role of multifunctional Chemerin in obesity and preclinical diabetes. Fatima SS; Butt Z; Bader N; Pathan AZ; Hussain S; Iqbal NT Obes Res Clin Pract; 2015; 9(5):507-12. PubMed ID: 25666091 [TBL] [Abstract][Full Text] [Related]
10. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Bozaoglu K; Bolton K; McMillan J; Zimmet P; Jowett J; Collier G; Walder K; Segal D Endocrinology; 2007 Oct; 148(10):4687-94. PubMed ID: 17640997 [TBL] [Abstract][Full Text] [Related]
11. Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the disease. Coimbra S; Brandão Proença J; Santos-Silva A; Neuparth MJ Biomed Res Int; 2014; 2014():701915. PubMed ID: 25105135 [TBL] [Abstract][Full Text] [Related]
12. [Relationship of serum Chemerin to obesity and type 2 diabetes mellitus]. Wang LY; Wei L; Yu HY; Zhang Y; Jia WP Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):235-8. PubMed ID: 19552838 [TBL] [Abstract][Full Text] [Related]
13. Cord blood chemerin: differential effects of gestational diabetes mellitus and maternal obesity. van Poppel MN; Zeck W; Ulrich D; Schest EC; Hirschmugl B; Lang U; Wadsack C; Desoye G Clin Endocrinol (Oxf); 2014 Jan; 80(1):65-72. PubMed ID: 23286837 [TBL] [Abstract][Full Text] [Related]
14. Adipocyte chemerin release is induced by insulin without being translated to higher levels in vivo. Bauer S; Bala M; Kopp A; Eisinger K; Schmid A; Schneider S; Neumeier M; Buechler C Eur J Clin Invest; 2012 Nov; 42(11):1213-20. PubMed ID: 22924572 [TBL] [Abstract][Full Text] [Related]
15. Serum Calprotectin and Chemerin Concentrations as Markers of Low-Grade Inflammation in Prepubertal Children with Obesity. Rowicka G; Dyląg H; Chełchowska M; Weker H; Ambroszkiewicz J Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33081030 [TBL] [Abstract][Full Text] [Related]
16. The association between clinically suspect arthralgia and adipokines in obese patients. Kose R; Sargin G; Senturk T; Cildag S; Unubol M; Abas Bİ; Yenisey C Acta Reumatol Port; 2018; 43(4):284-290. PubMed ID: 30641537 [TBL] [Abstract][Full Text] [Related]
17. Circulating Chemerin Is Associated With Carotid Plaque Instability, Whereas Resistin Is Related to Cerebrovascular Symptomatology. Gasbarrino K; Mantzoros C; Gorgui J; Veinot JP; Lai C; Daskalopoulou SS Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1670-8. PubMed ID: 27312219 [TBL] [Abstract][Full Text] [Related]
18. Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension. Eisinger K; Krautbauer S; Wiest R; Karrasch T; Hader Y; Scherer MN; Farkas S; Aslanidis C; Buechler C Eur J Clin Invest; 2013 Sep; 43(9):926-32. PubMed ID: 23855493 [TBL] [Abstract][Full Text] [Related]
19. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. Sell H; Divoux A; Poitou C; Basdevant A; Bouillot JL; Bedossa P; Tordjman J; Eckel J; Clément K J Clin Endocrinol Metab; 2010 Jun; 95(6):2892-6. PubMed ID: 20375212 [TBL] [Abstract][Full Text] [Related]
20. Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis. Horn P; von Loeffelholz C; Forkert F; Stengel S; Reuken P; Aschenbach R; Stallmach A; Bruns T Sci Rep; 2018 Jun; 8(1):9242. PubMed ID: 29915268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]